Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients

被引：0
|
作者：
Aarthi Manoharan
Deepak Gopal Shewade
Ravi Philip Rajkumar
Surendiran Adithan
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Department of Pharmacology
[2] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Department of Psychiatry
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
SLC6A4; Fluoxetine; Response; Major depression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1215 / 1220
页数：5
相关论文
共 50 条
  • [41] Serotonin Transporter Gene (SLC6A4) Polymorphism in Patients with Irritable Bowel Syndrome and Healthy Controls
    Kumar, Sunil
    Ranjan, Prabhat
    Mittal, Balraj
    Ghoshal, Uday C.
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (01) : 31 - 38
  • [42] Polymorphism of Serotonin Transporter SLC6A4 (5-HTTLPR) Gene in Cheilitis Angularis Patients
    Listyowati, Listyowati
    Ismail, Raden Irawati
    Partakusuma, Fatimah Boenjamin
    Suhartono, Antonius Winoto
    Auerkari, Elza Ibrahim
    [J]. PESQUISA BRASILEIRA EM ODONTOPEDIATRIA E CLINICA INTEGRADA, 2019, 19 (01):
  • [43] Characterization of serotonin transporter gene (SLC6A4) polymorphisms and its association with drug dependence in a Jordanian Arab population
    Al-Eitan, Laith Naser
    Jaradat, Saied Ali
    Qin, Wenwen
    Wildenauer, Diah Mutiara B.
    Wildenauer, Dieter D. B.
    Hulse, Gary K.
    Tay, Guan K.
    [J]. TOXICOLOGY AND INDUSTRIAL HEALTH, 2014, 30 (07) : 598 - 610
  • [44] THE SEROTONIN TRANSPORTER GENE SLC6A4, ENVIRONMENTAL ADVERSITY, AND HEAVY ALCOHOL CONSUMPTION
    Kramer, J. R.
    Chan, G.
    Wetherill, L.
    Bucholz, K. K.
    Schuckit, M. A.
    Edenberg, H.
    Dick, D.
    Xuei, X.
    Hesselbrock, V. M.
    Numberger, J., Jr.
    Foroud, T.
    Kuperman, S.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (06) : 133A - 133A
  • [45] New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype
    Lazary, Judit
    Lazary, Aron
    Gonda, Xenia
    Benko, Anita
    Molnar, Eszter
    Juhasz, Gabriella
    Bagdy, Gyorgy
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 64 (06) : 498 - 504
  • [46] Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population
    Li, Wenqiang
    Yang, Yongfeng
    Lin, Juntang
    Wang, Shuai
    Zhao, Jingyuan
    Yang, Ge
    Wang, Xiujuan
    Ding, Minli
    Zhang, Hongxing
    Lv, Luxian
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 44 : 290 - 295
  • [47] Polymorphism and linkage disequilibrium patterns at the serotonin transporter gene locus (SLC6A4)
    Mansour, HA
    Talkowski, ME
    Chowdari, KV
    Wood, JA
    Bamne, MN
    Fagiolini, A
    Frank, E
    Thase, ME
    Kupfer, DJ
    Nimgaonkar, VL
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2004, 130B (01): : 37 - 37
  • [48] Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism
    Coutinho, AM
    Oliveira, G
    Morgadinho, T
    Fesel, C
    Macedo, TR
    Bento, C
    Marques, C
    Ataíde, A
    Miguel, T
    Borges, L
    Vicente, AM
    [J]. MOLECULAR PSYCHIATRY, 2004, 9 (03) : 264 - 271
  • [49] Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder
    Ruhe, Henricus G.
    Ooteman, Wendy
    Booij, Jan
    Michel, Martin C.
    Moeton, Martina
    Baas, Frank
    Schene, Aart H.
    [J]. PHARMACOGENETICS AND GENOMICS, 2009, 19 (01): : 67 - 76
  • [50] Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder
    Ramesh, Varsha
    Venkatesan, Vettriselvi
    Ramasamy, Balakrishnan
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (04)
12345